Trial intelligence / Profile preview

Mycobacterium w in severe sepsis (MISS)

NCT02330432Phase 3Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Jan 2016
Primary completion
Oct 2018
Countries
1
01

Overview

A Phase 3 trial of MYCIDAC-C in sepsis, sponsored by Post Graduate Institute of Medical Education and Research. Started Jan 2016; status: completed.

02

Drugs

MYCIDAC-C
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT02330432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02330432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call